Filing Details
- Accession Number:
- 0001144204-17-002042
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-12 17:50:54
- Reporting Period:
- 2017-01-10
- Filing Date:
- 2017-01-12
- Accepted Time:
- 2017-01-12 17:50:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1557746 | Aclaris Therapeutics Inc. | ACRS | Pharmaceutical Preparations (2834) | 460571712 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1590102 | Anand Mehra | C/O Aclaris Therapeutics, Inc. 101 Lindenwood Drive, Suite 400 Malvern PA 19355 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-01-10 | 750,000 | $28.25 | 1,539,480 | No | 4 | S | Indirect | By Funds |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Funds |
Footnotes
- The shares are held of record by Sofinnova Venture Partners VIII, L.P. ("SVP VIII"). Sofinnova Management VIII, L.L.C. ("SM VIII") is the general partner of SVP VIII. The Reporting Person is a managing member of SM VIII and may be deemed to share voting and dispositive power over the shares held by SVP VIII. The Reporting Person disclaims beneficial ownership over the shares owned by SVP VIII except to the extent of any pecuniary interest therein.
Billionaire Hedge Funds
